SCHEMBL7093397

SCHEMBL7093397

O=C(Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)c1cccc(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 7/20 0.54
KDR P35968 3/20 0.53
CDK1 P06493 1/20 0.50
CDK2 P24941 1/20 0.50
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
KIT P10721 1/20 0.46
FLT1 P17948 1/20 0.46
MAPK14 Q16539 1/20 0.46
PDPK1 O15530 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NFKB1 P19838 1/20 0.45
HTT P42858 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
KDM4E B2RXH2 1/20 0.45
CASP3 P42574 1/20 0.45
SENP7 Q9BQF6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7091231 0.92 CHEK1 (0.56) CHEK1KDRCDK1CDK2KIT
SCHEMBL7088877 0.89 NPC1 (0.52) CHEK1KDRNPC1RAB9AKMT2A
SCHEMBL7696243 0.89 CHEK1 (0.57) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7094928 0.89 KDR (0.64) CHEK1KDRCDK1CDK2NPC1
Water SCHEMBL7089950 0.88 KDR (0.63) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7700585 0.85 CHEK1 (0.53) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL7702867 0.85 CHEK1 (0.53) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7701674 0.85 MEN1 (0.55) CHEK1KDRCDK1CDK2NPC1
SCHEMBL6994408 0.84 KDR (0.64) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7697888 0.83 CHEK1 (0.57) CHEK1KDRCDK1CDK2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed